Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study

• Anna‐Belle BeauInserm
• Erika-Alejandra CifuentesUniversité Toulouse III - Paul Sabatier
• Justine BéneventUniversité Toulouse III - Paul Sabatier
• Marie BeslayUniversité Toulouse III - Paul Sabatier
• Laia Barrachina‐BonetFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
• Jorieke E. H. BergmanUniversity Medical Center Groningen
• Clara Cavero‐CarbonellFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
• Alessio CoiIstituto di Fisiologia Clinica
• Helen M. DolkUniversity of Ulster
• Ester GarneLillebaelt Hospital
• Miriam GattMinistry for Health
• Jonathan HoareauUniversity of Reunion Island
• Elly Den HondProvincial Institute for Hygiene
• Anna Latos-BielenskaPoznan University of Medical Sciences
• Nathalie LelongInserm
• Mary O’mahonyHealth Service Executive
• Xavier MoissetInserm
• Joan K. MorrisSt George's, University of London
• Amanda J. NevilleUniversity of Ferrara
• Joanna SichitiuCentre Hospitalier Universitaire Vaudois
• Maria A. LoaneUniversity of Ulster
• Christine Damase‐MichelUniversité Toulouse III - Paul Sabatier